ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 35661925

Anti-cancer activities of Schedule E1 drugs used in ayurvedic formulations.

Vikram ENT and 2 others. J Ayurveda Integr Med, 2022. Cited by 3 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Anti-cancer activities of Schedule E1 drugs used in ayurvedic formulations. Papers, record 35661925. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35661925

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-cancer activities of Schedule E1 drugs used in ayurvedic formulations.
PubMed
Journal
J Ayurveda Integr Med
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.56
iCite
Revised in PubMed
2024-08-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vikram ENTE N T
2Ilavarasan RR
3Kamaraj RR

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References141

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115,297,423Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth.Clin Cancer Res2004https://conductscience.org/library/papers/15297423PubMed
225,811,651Progress Toward the Development of Noscapine and Derivatives as Anticancer Agents.J Med Chem2015https://conductscience.org/library/papers/25811651PubMed
328,860,749In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine.Int J Nanomedicine2017https://conductscience.org/library/papers/28860749PubMed
432,673,076Cancer Statistics, 2020: Report From National Cancer Registry Programme, India.JCO Glob Oncol2020https://conductscience.org/library/papers/32673076PubMed
523,701,597Cytotoxic phorbol esters of Croton tiglium.J Nat Prod2013https://conductscience.org/library/papers/23701597PubMed
610,861,074Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway.J Immunol2000https://conductscience.org/library/papers/10861074PubMed
717,572,113Apoptotic effect of Semecarpus anacardium nut extract on T47D breast cancer cell line.Cell Biol Int2007https://conductscience.org/library/papers/17572113PubMed
89,605,77512-O-tetradecanoylphorbol-13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase.Cancer Res1998https://conductscience.org/library/papers/9605775PubMed
97,500,639Ayurvedic herbal drugs with possible cytostatic activity.J Ethnopharmacol1995https://conductscience.org/library/papers/7500639PubMed
1024,023,444Evaluation of toxicity of 'Vatsanabha' (Aconitum ferox, Ranunculaceae) Before and After Shodhana.J Young Pharm2013https://conductscience.org/library/papers/24023444PubMed

1 to 10 of 141

See all 141 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

None in this release.

Genes34

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15,243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
ACHE43PubTator's text mininghttps://conductscience.org/library/genes/43NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ALOX5240PubTator's text mininghttps://conductscience.org/library/genes/240NCBI Gene
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BCHE590PubTator's text mininghttps://conductscience.org/library/genes/590NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
CASP1834PubTator's text mininghttps://conductscience.org/library/genes/834NCBI Gene
CASP10843PubTator's text mininghttps://conductscience.org/library/genes/843NCBI Gene
CASP1423,581PubTator's text mininghttps://conductscience.org/library/genes/23581NCBI Gene

1 to 10 of 34

See all 34 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35661925

GET https://conductscience.org/api/papers/v1/35661925/references?page=2

API referenceFor AI assistants